AG
ABBV icon

AIA Group’s AbbVie ABBV Stock Holding History

AIA Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4M Sell
57,308
-17,272
-23% -$3.72M 0.18% 80
2026
Q1 		$16.2M Buy
74,580
+14,163
+23% +$3.14M 0.24% 65
2025
Q4 		$13.8M Buy
60,417
+33,580
+125% +$7.65M 0.21% 73
2025
Q3 		$6.21M Buy
26,837
+15,295
+133% +$3.11M 0.11% 123
2025
Q2 		$2.14M Sell
11,542
-12,286
-52% -$2.28M 0.05% 169
2025
Q1 		$4.99M Sell
23,828
-786
-3% -$153K 0.12% 91
2024
Q4 		$4.37M Sell
24,614
-12,459
-34% -$2.29M 0.11% 92
2024
Q3 		$7.32M Sell
37,073
-10,861
-23% -$2.03M 0.19% 62
2024
Q2 		$8.22M Buy
47,934
+3,939
+9% +$652K 0.24% 51
2024
Q1 		$8.01M Buy
43,995
+32,295
+276% +$5.57M 0.26% 43
2023
Q4 		$1.81M Buy
11,700
+3,499
+43% +$510K 0.07% 131
2023
Q3 		$1.22M Buy
+8,201
New +$1.2M 0.06% 150
2023
Q2 		– Sell
-28,131
Closed -$4.48M – 320
2023
Q1 		$4.48M Sell
28,131
-3,951
-12% -$604K 0.24% 40
2022
Q4 		$5.18M Buy
32,082
+15,249
+91% +$2.34M 0.32% 35
2022
Q3 		$2.26M Sell
16,833
-16,569
-50% -$2.38M 0.15% 62
2022
Q2 		$5.12M Buy
33,402
+5,699
+21% +$871K 0.27% 45
2022
Q1 		$4.49M Sell
27,703
-1,630
-6% -$237K 0.2% 49
2021
Q4 		$3.97M Buy
29,333
+21,791
+289% +$2.57M 0.19% 63
2021
Q3 		$814K Sell
7,542
-6,733
-47% -$769K 0.05% 151
2021
Q2 		$1.65M Buy
14,275
+3,396
+31% +$382K 0.11% 89
2021
Q1 		$1.18M Buy
10,879
+4,474
+70% +$479K 0.17% 81
2020
Q4 		$685K Buy
+6,405
New +$616K 0.08% 100

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AIA Group's ABBV Position: Q2 2026 in Review

AIA Group reduced its AbbVie (ABBV) stake by 23% in Q2 2026, selling an estimated $3.72M and leaving 57,308 shares worth $14.4M. The position accounts for 0.18% of the portfolio, ranked #80.

AIA Group first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. The position peaked at $16.2M in Q1 2026. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • AIA Group held 57,308 shares of AbbVie worth $14.4M as of Q2 2026.
  • AIA Group sold 17,272 AbbVie shares in Q2 2026, an estimated $3.72M.
  • AbbVie made up 0.18% of AIA Group's portfolio in Q2 2026, its #80 holding.
  • AIA Group first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
  • AIA Group's AbbVie position peaked at $16.2M in Q1 2026.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on AIA Group's 13F filing for Q2 2026, filed 31 Jul 2026.